The effect of NG-monomethyl- l-arginine on bladder function

Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 1996-09, Vol.311 (1), p.73-78
1. Verfasser: Theobald, Robert J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 78
container_issue 1
container_start_page 73
container_title European journal of pharmacology
container_volume 311
creator Theobald, Robert J.
description Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold, and inhibition of pelvic nerve-evoked contractions by various stimuli. In naive, anesthetized adult cats, inhibition of pelvic nerve-evoked bladder contractions, induced by hypogastric nerve stimulation or the intraarterial administration of NA, ATP, adenosine, β,γ-methylene ATP and 2-methylthio ATP, was measured before and after inhibition of NO synthase. The micturition volume threshold was also measured before and after NO synthase inhibition. l-NMMA decreased the micturition volume threshold by 38% (2 mg intravesical administration) or 80% (4 mg/kg i.a.). The magnitude of the micturition contractions was modestly increased. These results, and information in the literature, indicate that NO may play a role in the collection phase of the bladder cycle and any alteration of nitric oxide availability could induce or allow development of various bladder malfunctions, such as small bladder diseases, like interstitial cystitis.
doi_str_mv 10.1016/0014-2999(96)00404-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78461329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0014299996004049</els_id><sourcerecordid>78461329</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2339-5a422472e340f329070e373744f6f1ac174d59b79a8c82b243b9f256609d0bab3</originalsourceid><addsrcrecordid>eNp9kE1LJDEQhoO46PjxDxT6ILJ7yFr56E4HQVjEdRdEL3oO6XRFI92JJjOC_95uZpijp6Ko530pHkJOGPxmwJoLACYp11r_1M0vAAmS6h2yYK3SFBTju2SxRfbJQSmvAFBrXu-RvbZtJRd6QS4fX7BC79Etq-Sr-1s6pphGXL58DrQaqM3PIYaIVYpVN9i-x1z5VXTLkOIR-eHtUPB4Mw_J09-bx-t_9O7h9v_1nzvquBCa1lZyLhVHIcELrkEBCiWUlL7xzDqmZF_rTmnbupZ3XIpOe143DegeOtuJQ3K-7n3L6X2FZWnGUBwOg42YVsWoVjZsKp5AuQZdTqVk9OYth9HmT8PAzM7MLMTMQoyel8mZmWOnm_5VN2K_DW0kTfezzd0WZwefbXShbDHBJ-W8mbCrNYaTi4-A2RQXMDrsQ570mj6F7__4AiqEhO0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78461329</pqid></control><display><type>article</type><title>The effect of NG-monomethyl- l-arginine on bladder function</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Theobald, Robert J.</creator><creatorcontrib>Theobald, Robert J.</creatorcontrib><description>Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold, and inhibition of pelvic nerve-evoked contractions by various stimuli. In naive, anesthetized adult cats, inhibition of pelvic nerve-evoked bladder contractions, induced by hypogastric nerve stimulation or the intraarterial administration of NA, ATP, adenosine, β,γ-methylene ATP and 2-methylthio ATP, was measured before and after inhibition of NO synthase. The micturition volume threshold was also measured before and after NO synthase inhibition. l-NMMA decreased the micturition volume threshold by 38% (2 mg intravesical administration) or 80% (4 mg/kg i.a.). The magnitude of the micturition contractions was modestly increased. These results, and information in the literature, indicate that NO may play a role in the collection phase of the bladder cycle and any alteration of nitric oxide availability could induce or allow development of various bladder malfunctions, such as small bladder diseases, like interstitial cystitis.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/0014-2999(96)00404-9</identifier><identifier>PMID: 8884239</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animals ; Arginine - pharmacology ; Biological and medical sciences ; Cats ; Enzyme Inhibitors - pharmacology ; Female ; Fundamental and applied biological sciences. Psychology ; Hypogastric Plexus - physiology ; Inhibition ; Male ; Micturition volume threshold ; Muscle Contraction - drug effects ; Muscle, Smooth - drug effects ; Muscle, Smooth - innervation ; Nitric oxide (NO) ; Nitric Oxide Synthase - antagonists &amp; inhibitors ; omega-N-Methylarginine - pharmacology ; Purinergic ; Purinergic Antagonists ; Sympathetic Nervous System - drug effects ; Urinary Bladder - drug effects ; Urinary Bladder - innervation ; Urination - drug effects ; Urodynamics - drug effects ; Vertebrates: urinary system</subject><ispartof>European journal of pharmacology, 1996-09, Vol.311 (1), p.73-78</ispartof><rights>1996</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2339-5a422472e340f329070e373744f6f1ac174d59b79a8c82b243b9f256609d0bab3</citedby><cites>FETCH-LOGICAL-c2339-5a422472e340f329070e373744f6f1ac174d59b79a8c82b243b9f256609d0bab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0014-2999(96)00404-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3218726$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8884239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Theobald, Robert J.</creatorcontrib><title>The effect of NG-monomethyl- l-arginine on bladder function</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold, and inhibition of pelvic nerve-evoked contractions by various stimuli. In naive, anesthetized adult cats, inhibition of pelvic nerve-evoked bladder contractions, induced by hypogastric nerve stimulation or the intraarterial administration of NA, ATP, adenosine, β,γ-methylene ATP and 2-methylthio ATP, was measured before and after inhibition of NO synthase. The micturition volume threshold was also measured before and after NO synthase inhibition. l-NMMA decreased the micturition volume threshold by 38% (2 mg intravesical administration) or 80% (4 mg/kg i.a.). The magnitude of the micturition contractions was modestly increased. These results, and information in the literature, indicate that NO may play a role in the collection phase of the bladder cycle and any alteration of nitric oxide availability could induce or allow development of various bladder malfunctions, such as small bladder diseases, like interstitial cystitis.</description><subject>Animals</subject><subject>Arginine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cats</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hypogastric Plexus - physiology</subject><subject>Inhibition</subject><subject>Male</subject><subject>Micturition volume threshold</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - innervation</subject><subject>Nitric oxide (NO)</subject><subject>Nitric Oxide Synthase - antagonists &amp; inhibitors</subject><subject>omega-N-Methylarginine - pharmacology</subject><subject>Purinergic</subject><subject>Purinergic Antagonists</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Urinary Bladder - drug effects</subject><subject>Urinary Bladder - innervation</subject><subject>Urination - drug effects</subject><subject>Urodynamics - drug effects</subject><subject>Vertebrates: urinary system</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LJDEQhoO46PjxDxT6ILJ7yFr56E4HQVjEdRdEL3oO6XRFI92JJjOC_95uZpijp6Ko530pHkJOGPxmwJoLACYp11r_1M0vAAmS6h2yYK3SFBTju2SxRfbJQSmvAFBrXu-RvbZtJRd6QS4fX7BC79Etq-Sr-1s6pphGXL58DrQaqM3PIYaIVYpVN9i-x1z5VXTLkOIR-eHtUPB4Mw_J09-bx-t_9O7h9v_1nzvquBCa1lZyLhVHIcELrkEBCiWUlL7xzDqmZF_rTmnbupZ3XIpOe143DegeOtuJQ3K-7n3L6X2FZWnGUBwOg42YVsWoVjZsKp5AuQZdTqVk9OYth9HmT8PAzM7MLMTMQoyel8mZmWOnm_5VN2K_DW0kTfezzd0WZwefbXShbDHBJ-W8mbCrNYaTi4-A2RQXMDrsQ570mj6F7__4AiqEhO0</recordid><startdate>19960905</startdate><enddate>19960905</enddate><creator>Theobald, Robert J.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960905</creationdate><title>The effect of NG-monomethyl- l-arginine on bladder function</title><author>Theobald, Robert J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2339-5a422472e340f329070e373744f6f1ac174d59b79a8c82b243b9f256609d0bab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Arginine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cats</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hypogastric Plexus - physiology</topic><topic>Inhibition</topic><topic>Male</topic><topic>Micturition volume threshold</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - innervation</topic><topic>Nitric oxide (NO)</topic><topic>Nitric Oxide Synthase - antagonists &amp; inhibitors</topic><topic>omega-N-Methylarginine - pharmacology</topic><topic>Purinergic</topic><topic>Purinergic Antagonists</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Urinary Bladder - drug effects</topic><topic>Urinary Bladder - innervation</topic><topic>Urination - drug effects</topic><topic>Urodynamics - drug effects</topic><topic>Vertebrates: urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Theobald, Robert J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Theobald, Robert J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of NG-monomethyl- l-arginine on bladder function</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1996-09-05</date><risdate>1996</risdate><volume>311</volume><issue>1</issue><spage>73</spage><epage>78</epage><pages>73-78</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold, and inhibition of pelvic nerve-evoked contractions by various stimuli. In naive, anesthetized adult cats, inhibition of pelvic nerve-evoked bladder contractions, induced by hypogastric nerve stimulation or the intraarterial administration of NA, ATP, adenosine, β,γ-methylene ATP and 2-methylthio ATP, was measured before and after inhibition of NO synthase. The micturition volume threshold was also measured before and after NO synthase inhibition. l-NMMA decreased the micturition volume threshold by 38% (2 mg intravesical administration) or 80% (4 mg/kg i.a.). The magnitude of the micturition contractions was modestly increased. These results, and information in the literature, indicate that NO may play a role in the collection phase of the bladder cycle and any alteration of nitric oxide availability could induce or allow development of various bladder malfunctions, such as small bladder diseases, like interstitial cystitis.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>8884239</pmid><doi>10.1016/0014-2999(96)00404-9</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 1996-09, Vol.311 (1), p.73-78
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_78461329
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Arginine - pharmacology
Biological and medical sciences
Cats
Enzyme Inhibitors - pharmacology
Female
Fundamental and applied biological sciences. Psychology
Hypogastric Plexus - physiology
Inhibition
Male
Micturition volume threshold
Muscle Contraction - drug effects
Muscle, Smooth - drug effects
Muscle, Smooth - innervation
Nitric oxide (NO)
Nitric Oxide Synthase - antagonists & inhibitors
omega-N-Methylarginine - pharmacology
Purinergic
Purinergic Antagonists
Sympathetic Nervous System - drug effects
Urinary Bladder - drug effects
Urinary Bladder - innervation
Urination - drug effects
Urodynamics - drug effects
Vertebrates: urinary system
title The effect of NG-monomethyl- l-arginine on bladder function
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A20%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20NG-monomethyl-%20l-arginine%20on%20bladder%20function&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Theobald,%20Robert%20J.&rft.date=1996-09-05&rft.volume=311&rft.issue=1&rft.spage=73&rft.epage=78&rft.pages=73-78&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/0014-2999(96)00404-9&rft_dat=%3Cproquest_cross%3E78461329%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78461329&rft_id=info:pmid/8884239&rft_els_id=0014299996004049&rfr_iscdi=true